Skip to content
GeoClinicalTrials
Back to search

NCT07171658Recruiting

Breast Cancer-Related Approach for Increasing Cervical Cancer Screening

Official recordSimplified version

Summary

The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland. This randomized trial will compare three arms: 1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment. 2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection 3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.

Inclusion criteria

• Women receiving Breast Cancer Screening (BCS) invitation letters in the selected five cantons (Geneva, Bern (francophone), Jura, Neuchâtel, and Vaud) • Aged 50 to 74 years old • Not been screened for cervical cancer in the past three years • Speaking one of the 6 languages of the study (French, German, Italian, and in English, Spanish, and Portuguese)

Exclusion criteria

• Prior cervical cancer diagnosis, • Hysterectomy • Non consent to participate to the study • Incapable of judgment or under tutelage • Pregnancy

Contacts

The trial team's contact details are shown on request.

See the official trial record
Status
Recruiting
Phase
No phase (N/A)
Study type
Interventional
Countries
Switzerland
Sponsor
Jessica Di Vincenzo Sormani(Other)
Protocol no.
32HW-0_228666
Conditions
Cervical Cancer Screening
Interventions
Behavioral

Treatments studied

  • Sensitization to Cervical Cancer (CC) screening
  • Home-based HPV self-sampling

Collaborators

University Hospital, Geneva

Locations · 1

  • Geneva, SwitzerlandUniversity Hospitals of GenevaRecruiting at this site

In total, worldwide, the only site listed in the registry is recruiting.

Site status per the ClinicalTrials.gov registry (last update posted: December 22, 2025).

This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.

See also

Other versions

These results are indicative and do not replace medical advice — discuss them with your doctor.